Clinical TrialsIpsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Ipsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Read Post »
Clinical TrialsINmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... INmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... Read Post »
Clinical TrialsBiocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Biocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Read Post »
Health Tidings Mergers & AcquisitionsTeva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Teva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Read Post »
Health Tidings Mergers & AcquisitionsBayer Launches Clinical Trials Alliance With CU Anschutz Bayer Launches Clinical Trials Alliance With CU Anschutz Read Post »
GenericsTeva, Samsung Bioepis Partner to Commercialize OPUVIZ Aflibercept Biosimila... Teva, Samsung Bioepis Partner to Commercialize OPUVIZ Aflibercept Biosimila... Read Post »
Health TidingsAllotera Secures $35M to Advance Pivotal Allogeneic CAR‑T Sofi‑cel in T... Allotera Secures $35M to Advance Pivotal Allogeneic CAR‑T Sofi‑cel in T... Read Post »
Clinical TrialsBiocon Reports New Phase III Evidence for Yesafili Biosimilar Biocon Reports New Phase III Evidence for Yesafili Biosimilar Read Post »
Clinical TrialsAstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial AstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial Read Post »
Clinical TrialsSatellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Satellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Read Post »
Clinical TrialsRhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Rhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Read Post »
Health TidingsMerck Secures FDA Breakthrough Therapy Designation for Enpatoran in Lupus P... Merck Secures FDA Breakthrough Therapy Designation for Enpatoran in Lupus P... Read Post »
Clinical TrialsPrilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Prilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Read Post »
Clinical TrialsUCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... UCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... Read Post »
Health TidingsGrünenthal Receives FDA Orphan Drug and Rare Pediatric Disease Designation... Grünenthal Receives FDA Orphan Drug and Rare Pediatric Disease Designation... Read Post »
Health TidingsArcutis’ ZORYVE Cream sNDA Accepted by FDA for Infants with Atopic Dermat... Arcutis’ ZORYVE Cream sNDA Accepted by FDA for Infants with Atopic Dermat... Read Post »
Clinical TrialsMAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... MAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... Read Post »
Health Tidings Mergers & AcquisitionsSino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Sino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Read Post »
Health TidingsImmunome’s Varegacestat NDA Accepted by FDA for Desmoid Tumors Immunome’s Varegacestat NDA Accepted by FDA for Desmoid Tumors Read Post »
Health Tidings Mergers & AcquisitionsChemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Chemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Read Post »
Clinical TrialsKeenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Keenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Read Post »
Clinical TrialsSeres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Seres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Read Post »
New Drug ApprovalMHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... MHRA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis and Progressi... Read Post »
Health TidingsFDA Aligns With OKYO’s NEPTUNE Phase 3 Trial of Urcosimod in Neuropathic ... FDA Aligns With OKYO’s NEPTUNE Phase 3 Trial of Urcosimod in Neuropathic ... Read Post »
Health TidingsVanda’s VCA-894A Receives FDA Rare Pediatric Disease Designation for Ultr... Vanda’s VCA-894A Receives FDA Rare Pediatric Disease Designation for Ultr... Read Post »
ResearchGalderma Global Survey Reveals Skin Quality Concerns Affect 90% of People, ... Galderma Global Survey Reveals Skin Quality Concerns Affect 90% of People, ... Read Post »
Health TidingsAgios’ Mitapivat Gains FDA Priority Review for Sickle Cell Disease Agios’ Mitapivat Gains FDA Priority Review for Sickle Cell Disease Read Post »
Clinical TrialsTurn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Turn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Read Post »
New Drug ApprovalFDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy FDA Grants Accelerated Approval to TRUTAKNA for IgA Nephropathy Read Post »
Health TidingsAxsome Moves Solriamfetol into Late-Stage Trial for Children with ADHD Axsome Moves Solriamfetol into Late-Stage Trial for Children with ADHD Read Post »
Health Tidings Mergers & AcquisitionsPraxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Praxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Read Post »
Health TidingsFDA Confirms Phase 3 Path for Alterity’s ATH434 in Multiple System Atroph... FDA Confirms Phase 3 Path for Alterity’s ATH434 in Multiple System Atroph... Read Post »
New Drug ApprovalFDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... FDA Expands WILATE Prophylaxis Approval to Children Under 6 With von Willeb... Read Post »
Health TidingsMeiraGTx Wins Up to $400 Million Funding for Gene Therapy Pipeline MeiraGTx Wins Up to $400 Million Funding for Gene Therapy Pipeline Read Post »
Health TidingsRevolution Medicines Advances Daraxonrasib Toward Europe After EMA Starts P... Revolution Medicines Advances Daraxonrasib Toward Europe After EMA Starts P... Read Post »
Health TidingsInsilico Medicine Advances AI-Discovered Rentosertib into Phase III Trial f... Insilico Medicine Advances AI-Discovered Rentosertib into Phase III Trial f... Read Post »
Clinical TrialsCompass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Compass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Read Post »
Clinical TrialsTeva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Teva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Read Post »
Clinical TrialsHengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Hengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Read Post »
Clinical TrialsTvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Tvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Read Post »
Clinical TrialsItalfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Italfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Read Post »
Health TidingsNanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in... NanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in... Read Post »
Health TidingsChina Accepts Astellas’ PADCEV Plus Keytruda Filing for Muscle-Invasi... China Accepts Astellas’ PADCEV Plus Keytruda Filing for Muscle-Invasi... Read Post »
Health TidingsFDA Accepts Organogenesis’ ReNu® BLA for Symptomatic Knee Osteoarthr... FDA Accepts Organogenesis’ ReNu® BLA for Symptomatic Knee Osteoarthr... Read Post »
Health Tidings Mergers & AcquisitionsVertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Vertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Read Post »
New Drug ApprovalEU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... EU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... Read Post »
Clinical TrialsTG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... Read Post »
GenericsGlenmark Launches Generic Olanzapine for Injection in the US, Expanding Ins... Glenmark Launches Generic Olanzapine for Injection in the US, Expanding Ins... Read Post »
ResearchExperimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Experimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Read Post »
New Drug ApprovalMHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... MHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... Read Post »
